Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of $5.00 million. The enterprise value is $5.56 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 1.48 million shares outstanding. The number of shares has increased by 40.07% in one year.
| Current Share Class | 1.48M |
| Shares Outstanding | 1.48M |
| Shares Change (YoY) | +40.07% |
| Shares Change (QoQ) | +42.27% |
| Owned by Insiders (%) | 7.65% |
| Owned by Institutions (%) | 10.86% |
| Float | 890,538 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.13 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42
| Current Ratio | 0.42 |
| Quick Ratio | 0.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -176.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -67.31% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 157.12% |
| Revenue Per Employee | $37,378 |
| Profits Per Employee | -$573,545 |
| Employee Count | 15 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -97,279 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.54% in the last 52 weeks. The beta is 0.71, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -95.54% |
| 50-Day Moving Average | 4.22 |
| 200-Day Moving Average | 9.73 |
| Relative Strength Index (RSI) | 47.24 |
| Average Volume (20 Days) | 1,309,645 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XAGE had revenue of $560,671 and -$8.60 million in losses. Loss per share was -$11.19.
| Revenue | 560,671 |
| Gross Profit | 313,784 |
| Operating Income | -5.12M |
| Pretax Income | n/a |
| Net Income | -8.60M |
| EBITDA | -5.04M |
| EBIT | -5.12M |
| Loss Per Share | -$11.19 |
Full Income StatementBalance Sheet
The company has $770,047 in cash and $776,588 in debt, giving a net cash position of -$6,541 or -$0.00 per share.
| Cash & Cash Equivalents | 770,047 |
| Total Debt | 776,588 |
| Net Cash | -6,541 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | -3.81M |
| Book Value Per Share | -3.79 |
| Working Capital | -3.81M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.07M |
| FCF Per Share | -$2.74 |
Full Cash Flow StatementMargins
| Gross Margin | 55.97% |
| Operating Margin | -914.07% |
| Pretax Margin | -1,551.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |